We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
-2.06%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$268M
AUM Growth
-$59.5M
(-18%)
Cap. Flow
-$50.9M
Cap. Flow
% of AUM
-19%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$9.9M |
| 2 |
Abbott
ABT
|
+$8.03M |
| 3 |
Johnson & Johnson
JNJ
|
+$7.21M |
| 4 |
Becton Dickinson
BDX
|
+$6.5M |
| 5 |
Elevance Health
ELV
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$9.44M |
| 2 |
Danaher
DHR
|
+$9.11M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$7.69M |
| 4 |
VanEck Biotech ETF
BBH
|
+$6.22M |
| 5 |
Sabra Healthcare REIT
SBRA
|
+$6.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.35% |
| 2 | Real Estate | 1.88% |
| 3 | Financials | 1.53% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $17.2M | 6.44% |
102,391
+25,900
| +34% | +$4.34M |
|
|
2
Abbott
ABT
$183B
| $16.6M | 6.19% |
276,732
+133,349
| +93% | +$8.03M |
|
|
3
Johnson & Johnson
JNJ
$618B
| $14.6M | 5.46% |
114,111
+53,311
| +88% | +$7.21M |
|
4
Medtronic
MDT
$109B
| $10.8M | 4.05% |
135,115
+18,800
| +16% | +$1.55M |
|
|
5
Becton Dickinson
BDX
$45.6B
| $10.6M | 3.97% |
50,256
+29,684
| +144% | +$6.5M |
|
6
Boston Scientific
BSX
$69.5B
| $10.6M | 3.96% |
387,698
+45,100
| +13% | +$1.23M |
|
|
7
Universal Health Services
UHS
$10.2B
| $9.88M | 3.69% |
+83,400
| New | +$9.9M |
|
8
UnitedHealth
UNH
$376B
| $9.72M | 3.63% |
45,408
+6,752
| +17% | +$1.54M |
|
|
9
Elevance Health
ELV
$81.5B
| $9.69M | 3.62% |
44,105
+21,594
| +96% | +$5.07M |
|
10
Merck
MRK
$322B
| $9.41M | 3.51% |
180,990
+69,797
| +63% | +$3.77M |
|
11
DaVita
DVA
$15.4B
| $9.32M | 3.48% |
141,336
-73,377
| -34% | -$5.39M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $8.07M | 3.01% |
53,996
+21,300
| +65% | +$2.93M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $7.87M | 2.94% |
120,223
-60,000
| -33% | -$4.29M |
|
|
SYNH
14
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.83M | 2.55% |
192,400
+79,500
| +70% | +$3.11M |
|
15
CVS Health
CVS
$133B
| $6.48M | 2.42% |
104,111
+50,811
| +95% | +$3.65M |
|
16
Viatris
VTRS
$20.4B
| $6.44M | 2.41% |
156,487
+37,600
| +32% | +$1.6M |
|
|
HOLX
17
DELISTED
Hologic
HOLX
| $6.39M | 2.39% |
170,944
-51,900
| -23% | -$2.1M |
|
|
18
Sabra Healthcare REIT
SBRA
$5.34B
| $5.03M | 1.88% |
285,219
-349,200
| -55% | -$6.16M |
|
19
Thermo Fisher Scientific
TMO
$213B
| $4.92M | 1.84% |
23,808
-19,800
| -45% | -$4.16M |
|
20
Labcorp
LH
$25B
| $4.78M | 1.79% |
34,425
+10,476
| +44% | +$1.54M |
|
21
HCA Healthcare
HCA
$87.2B
| $4.35M | 1.62% |
+44,800
| New | +$4.35M |
|
22
Pediatrix Medical
MD
$2.18B
| $4.13M | 1.54% |
74,217
-107,500
| -59% | -$5.89M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $4.11M | 1.53% |
24,312
-15,115
| -38% | -$2.72M |
|
|
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
| $3.79M | 1.41% |
54,790
-19,900
| -27% | -$1.52M |
|
25
Gilead Sciences
GILD
$162B
| $3.56M | 1.33% |
+47,200
| New | +$3.75M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Endurant Capital Management held 92 positions worth $268M, down 18% from $327M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Endurant Capital Management withdrew a net $50.9M in Q1 2018, closing 23 positions and reducing 32 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $6.22M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 86% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Endurant Capital Management opened a new position in Universal Health Services worth $9.88M.
- Endurant Capital Management's largest Q1 2018 buy was Universal Health Services: 83,400 shares worth $9.88M.
- Endurant Capital Management added most to Abbott in Q1 2018, an estimated $8.03M increase.
- Endurant Capital Management's biggest Q1 2018 reduction was McKesson, cutting an estimated $9.44M.
- Endurant Capital Management fully exited VanEck Biotech ETF in Q1 2018, selling an estimated $6.22M.
- Endurant Capital Management's ten largest holdings make up 45% of its $268M portfolio in Q1 2018.
- Endurant Capital Management opened 17 new positions and closed 23 in Q1 2018.
- Endurant Capital Management's portfolio value fell 18% quarter-over-quarter to $268M.
Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.